MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

TIOBE Index for January 2026: Top 10 Most Popular Programming Languages Your email has been sent January’s TIOBE Index begins the year with familiar names still setting the pace, but the underlying ...

SpaceX continues to accelerate production of its next-generation Starship vehicles at the Starfactory facility ...

Do you need to repay your PPP loan? Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the impact of technology ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...